Press Releases Synlogic, Inc.

Equities

SYBX

US87166L2097

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-06 pm EDT			5-day change	1st Jan Change
1.84 ^USD	0.00%		-1.60%	-52.21%

Mar. 21	Synlogic, Inc. Announces Board Changes	CI
Mar. 21	North American Morning Briefing : Investors -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 19	AQ
Synlogic Adopts Limited Duration Stockholders Rights Plan	Feb. 20	AQ
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update	Feb. 08	AQ
Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria	Feb. 02	AQ
Synlogic Provides Corporate Update and Outlook for 2024	Jan. 04	AQ
Synlogic Announces Contract with the Air Force Research Lab	Dec. 27	AQ
Synlogic : Corporate Presentation, December 2023	Dec. 19	PU
Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023	Dec. 07	AQ
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 09	AQ
Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration	Nov. 07	AQ
Synlogic : Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration - Form 8-K	Nov. 07	PU
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering	23-10-03	AQ
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering	23-09-29	AQ
Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism	23-09-28	AQ
Phenylketonuria Pipeline, Emerging Drugs, Clinical Trials, and FDA Approvals 2023 (Updated)	23-09-28	AQ
Synlogic Announces Reverse Stock Split	23-09-27	GL
Synlogic Announces Reverse Stock Split	23-09-27	AQ
Synlogic to Participate in Chardan’s Genetic Medicines Conference	23-09-21	AQ
Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100	23-09-19	AQ
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update	23-08-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Synlogic, Inc.

Equities

SYBX

US87166L2097

Press Releases

Filters